MYRIAD GENETICS INC
MYGNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for MYGN. That does not mean none is planned.
Get an email about MYGN's next catalysts
Track MYRIAD GENETICS (MYGN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (precision medicine), assess a patient's risk of disease progression and disease recurrence (precision medicine), and measure disease activity.
Website| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Niraparib | Phase 3 | Ovarian Neoplasms | - | - |
Oral rucaparib | Phase 2 | Ovarian Cancer | - | - |
Frequently asked questions
What is in MYRIAD GENETICS INC's drug pipeline?→
CatalystAlert tracks 2 drug candidates in MYRIAD GENETICS INC's (MYGN) pipeline across Phase 3, Phase 2. Its lead program is Niraparib (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MYRIAD GENETICS INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for MYRIAD GENETICS INC (MYGN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track MYGN biotech catalysts?→
Add MYGN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MYRIAD GENETICS INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.